Search For

Commentary on: ribozyme-activated RNA trans-ligation: an emerging strategy for large gene delivery in muscular dystrophies

Commentary on gait analysis in Duchenne muscular dystrophy: integrating contracture, strength, and kinematic perspectives

The critical importance of recognizing Gaucher disease in the fifth decade and beyond

Adeno-associated viral vector gene therapy for canine hemophilia

Plexiform neurofibromas in neurofibromatosis type 1: current and emergent therapeutic strategies

Emerging treatments for systemic lupus erythematosus

Meeting Abstracts from the XVI International Collaboration on Rare Diseases and Orphan Drugs (ICORD): Incentivizing Science and a Comprehensive Program for Rare Diseases

Management strategies for systemic lupus erythematosus using kinase inhibitors

Educating hematologists about Gaucher disease

Neurofibromatosis type 2-related schwannomatosis: an update

Evidence evaluation in rare disease guidelines: a methodological perspective

Recognizing Gaucher disease in the fifth decade and beyond: a retrospective case study in patients of Ashkenazi Jewish descent